Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-22

FDA Approved: IBUPROFEN — Supplemental Application (Aurohealth LLC)

View source ↗

Summary

The FDA approved a supplemental application for ibuprofen filed by Aurohealth LLC, authorizing the generic ibuprofen product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

SUPPL AP for IBUPROFEN (IBUPROFEN)